These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 16306936

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M, Goodbody R, Schröder M, Stack J, Moynagh PN, Bowie AG.
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [Abstract] [Full Text] [Related]

  • 23. Antiviral signaling through pattern recognition receptors.
    Kawai T, Akira S.
    J Biochem; 2007 Feb; 141(2):137-45. PubMed ID: 17190786
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway.
    Martin DA, Elkon KB.
    Arthritis Rheum; 2006 Mar; 54(3):951-62. PubMed ID: 16508978
    [Abstract] [Full Text] [Related]

  • 32. DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation.
    Kim SS, Lee KG, Chin CS, Ng SK, Pereira NA, Xu S, Lam KP.
    J Immunol; 2014 Jul 15; 193(2):840-8. PubMed ID: 24929003
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    J Med Virol; 2008 Jun 15; 80(6):980-8. PubMed ID: 18428149
    [Abstract] [Full Text] [Related]

  • 35. Isoliquiritigenin suppresses the Toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of Toll-like receptors by targeting TBK1.
    Park SJ, Youn HS.
    J Agric Food Chem; 2010 Apr 28; 58(8):4701-5. PubMed ID: 20356041
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C, Eisenächer K, Gross O, Reindl W, Schmitz F, Ruland J, Krug A.
    Eur J Immunol; 2009 Apr 28; 39(4):1007-18. PubMed ID: 19283778
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.